Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × Chemotherapy, Adjuvant × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Rectal Neoplasms 5 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Colonic Neoplasms 3 Central Nervous System Neoplasms 3 Breast Neoplasms, Male 3 Brain Neoplasms 3 Adenocarcinoma Of Esophagus 3 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioblastoma 2 Breast Carcinoma In Situ 2 Vomiting 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nausea 1 Medulloblastoma 1 Lymphoma, Follicular 1

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡